Avid Bioservices, Inc. (CDMO)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch CDMO
See up to 3 months of CDMO. The 7-day demo opens the 1M and 3M ranges and puts CDMO on your watchlist.
Start 7-day demoLatest CDMO insider trades
About Avid Bioservices, Inc. (CDMO)
The SEC lists Avid Bioservices, Inc. under CIK 0000704562, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
CDMO Form 4 activity by transaction type, last 90 days
No Form 4 activity for CDMO in the last 90 days.
CDMO insider transactions (Form 4)
9115 Form 4 filings on record, the earliest from Oct 11, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Richard A. Richieri - Officer | Option exercise | Common Stock, $0.001 par value | 10,695 | - | - | |
| Richard A. Richieri - Officer | Open-market sale | Common Stock, $0.001 par value | 3,843 | $12.22 | $47K | |
| Richard A. Richieri - Officer | Derivative | Performance Stock Units (FY 2023 Grant) | 5,043 | $0.00 | - | |
| Richard A. Richieri - Officer | Derivative | Performance Stock Units (FY 2023 Grant) | 5,044 | $0.00 | - | |
| Richard A. Richieri - Officer | Derivative | Performance Stock Units (FY 2024 Grant) | 5,652 | $0.00 | - | |
| Richard A. Richieri - Officer | Derivative | Performance Stock Units (FY 2024 Grant) | 5,652 | $0.00 | - | |
| Matthew R. Kwietniak - Officer | Option exercise | Common Stock, $0.001 par value | 9,300 | - | - | |
| Matthew R. Kwietniak - Officer | Option exercise | Common Stock, $0.001 par value | 29,479 | - | - | |
| Matthew R. Kwietniak - Officer | Open-market sale | Common Stock, $0.001 par value | 3,225 | $12.22 | $39K | |
| Matthew R. Kwietniak - Officer | Open-market sale | Common Stock, $0.001 par value | 10,165 | $12.22 | $124K | |
| Matthew R. Kwietniak - Officer | Derivative | Restricted Stock Units | 1,005 | $0.00 | - | |
| Matthew R. Kwietniak - Officer | Derivative | Restricted Stock Units | 1,893 | $0.00 | - | |
| Matthew R. Kwietniak - Officer | Derivative | Restricted Stock Units | 1,908 | $0.00 | - | |
| Matthew R. Kwietniak - Officer | Derivative | Restricted Stock Units | 4,494 | $0.00 | - | |
| Matthew R. Kwietniak - Officer | Derivative | Performance Stock Units (FY 2023 Grant) | 6,725 | $0.00 | - | |
| Matthew R. Kwietniak - Officer | Derivative | Performance Stock Units (FY 2023 Grant) | 6,725 | $0.00 | - | |
| Matthew R. Kwietniak - Officer | Derivative | Performance Stock Units (FY 2024 Grant) | 6,782 | $0.00 | - | |
| Matthew R. Kwietniak - Officer | Derivative | Performance Stock Units (FY 2024 Grant) | 6,782 | $0.00 | - | |
| Matthew R. Kwietniak - Officer | Derivative | Performance Stock Units (FY 2025 Grant) | 15,972 | $0.00 | - | |
| Matthew R. Kwietniak - Officer | Derivative | Performance Stock Units (FY 2025 Grant) | 15,972 | $0.00 | - | |
| Nicholas Stewart Green - Officer | Option exercise | Common Stock, $0.001 par value | 119,973 | - | - | |
| Nicholas Stewart Green - Officer | Option exercise | Common Stock, $0.001 par value | 183,558 | - | - | |
| Nicholas Stewart Green - Officer | Open-market sale | Common Stock, $0.001 par value | 57,675 | $12.22 | $705K | |
| Nicholas Stewart Green - Officer | Open-market sale | Common Stock, $0.001 par value | 88,236 | $12.22 | $1.08M | |
| Nicholas Stewart Green - Officer | Derivative | Restricted Stock Units | 16,721 | $0.00 | - | |
| Nicholas Stewart Green - Officer | Derivative | Restricted Stock Units | 26,479 | $0.00 | - | |
| Nicholas Stewart Green - Officer | Derivative | Restricted Stock Units | 25,434 | $0.00 | - | |
| Nicholas Stewart Green - Officer | Derivative | Restricted Stock Units | 51,339 | $0.00 | - | |
| Nicholas Stewart Green - Officer | Derivative | Performance Stock Units (FY 2023 Grant) | 47,073 | $0.00 | - | |
| Nicholas Stewart Green - Officer | Derivative | Performance Stock Units (FY 2023 Grant) | 47,073 | $0.00 | - | |
| Nicholas Stewart Green - Officer | Derivative | Performance Stock Units (FY 2024 Grant) | 45,215 | $0.00 | - | |
| Nicholas Stewart Green - Officer | Derivative | Performance Stock Units (FY 2024 Grant) | 45,215 | $0.00 | - | |
| Nicholas Stewart Green - Officer | Derivative | Performance Stock Units (FY 2025 Grant) | 91,270 | $0.00 | - | |
| Nicholas Stewart Green - Officer | Derivative | Performance Stock Units (FY 2025 Grant) | 91,270 | $0.00 | - | |
| Daniel R. Hart - Officer | Option exercise | Common Stock, $0.001 par value | 4,279 | - | - | |
| Daniel R. Hart - Officer | Option exercise | Common Stock, $0.001 par value | 45,328 | - | - | |
| Daniel R. Hart - Officer | Open-market sale | Common Stock, $0.001 par value | 1,968 | $12.22 | $24K | |
| Daniel R. Hart - Officer | Open-market sale | Common Stock, $0.001 par value | 20,845 | $12.22 | $255K | |
| Daniel R. Hart - Officer | Derivative | Restricted Stock Units | 4,279 | $0.00 | - | |
| Daniel R. Hart - Officer | Derivative | Performance Stock Units (FY 2023 Grant) | 11,208 | $0.00 | - | |
| Daniel R. Hart - Officer | Derivative | Performance Stock Units (FY 2023 Grant) | 11,208 | $0.00 | - | |
| Daniel R. Hart - Officer | Derivative | Performance Stock Units (FY 2024 Grant) | 11,303 | $0.00 | - | |
| Daniel R. Hart - Officer | Derivative | Performance Stock Units (FY 2024 Grant) | 11,304 | $0.00 | - | |
| Daniel R. Hart - Officer | Derivative | Performance Stock Units (FY 2025 Grant) | 22,817 | $0.00 | - | |
| Daniel R. Hart - Officer | Derivative | Performance Stock Units (FY 2025 Grant) | 22,818 | $0.00 | - | |
| Nicholas Stewart Green - Officer | Open-market sale | Common Stock, $0.001 par value | 75,000 | $12.31 | $923K | |
| Nicholas Stewart Green - Officer | Open-market sale | Common Stock, $0.001 par value | 100,000 | $12.28 | $1.23M | |
| Nicholas Stewart Green - Officer | Open-market sale | Common Stock, $0.001 par value | 51,653 | $12.27 | $634K | |
| Esther M. Alegria - Director | Option exercise | Common Stock, $0.001 par value | 26,756 | - | - | |
| Esther M. Alegria - Director | Option exercise | Restricted Stock Units | 26,756 | $0.00 | - | |
| Esther M. Alegria - Director | Grant or award | Restricted Stock Units | 8,147 | $0.00 | - | |
 Jeanne Thoma - Director | Option exercise | Common Stock, $0.001 par value | 26,756 | - | - | |
| Jeanne Thoma - Director | Option exercise | Restricted Stock Units | 26,756 | $0.00 | - | |
| Jeanne Thoma - Director | Grant or award | Restricted Stock Units | 8,147 | $0.00 | - | |
| Richard B. Hancock - Director | Option exercise | Common Stock, $0.001 par value | 26,756 | - | - | |
| Richard B. Hancock - Director | Option exercise | Restricted Stock Units | 26,756 | $0.00 | - | |
| Richard B. Hancock - Director | Grant or award | Restricted Stock Units | 8,147 | $0.00 | - | |
| Catherine J. Mackey - Director | Option exercise | Common Stock, $0.001 par value | 26,756 | - | - | |
| Catherine J. Mackey - Director | Option exercise | Restricted Stock Units | 26,756 | $0.00 | - | |
| Catherine J. Mackey - Director | Grant or award | Restricted Stock Units | 8,147 | $0.00 | - | |
 Gregory Sargen - Director | Option exercise | Common Stock, $0.001 par value | 26,756 | - | - | |
| Gregory Sargen - Director | Option exercise | Restricted Stock Units | 26,756 | $0.00 | - | |
| Gregory Sargen - Director | Grant or award | Restricted Stock Units | 8,147 | $0.00 | - | |
| Joseph Carleone - Director | Option exercise | Common Stock, $0.001 par value | 26,756 | - | - | |
| Joseph Carleone - Director | Option exercise | Restricted Stock Units | 26,756 | $0.00 | - | |
| Joseph Carleone - Director | Grant or award | Restricted Stock Units | 8,147 | $0.00 | - | |
| Matthew R. Kwietniak - Officer | Option exercise | Common Stock, $0.001 par value | 335 | - | - | |
| Matthew R. Kwietniak - Officer | Open-market sale | Common Stock, $0.001 par value | 119 | $10.15 | $1K | |
| Matthew R. Kwietniak - Officer | Option exercise | Restricted Stock Units | 335 | $0.00 | - | |
| Richard A. Richieri - Officer | Option exercise | Common Stock, $0.001 par value | 5,506 | - | - | |
| Richard A. Richieri - Officer | Open-market sale | Common Stock, $0.001 par value | 2,031 | $10.05 | $20K | |
| Richard A. Richieri - Officer | Option exercise | Common Stock, $0.001 par value | 462 | - | - | |
| Richard A. Richieri - Officer | Open-market sale | Common Stock, $0.001 par value | 201 | $10.05 | $2K | |
| Richard A. Richieri - Officer | Derivative | Restricted Stock Units | 507 | $0.00 | - | |
| Richard A. Richieri - Officer | Derivative | Restricted Stock Units | 945 | $0.00 | - | |
| Richard A. Richieri - Officer | Derivative | Restricted Stock Units | 1,060 | $0.00 | - | |
| Richard A. Richieri - Officer | Derivative | Restricted Stock Units | 2,994 | $0.00 | - | |
| Richard A. Richieri - Officer | Derivative | Restricted Stock Units | 40 | $0.00 | - | |
| Richard A. Richieri - Officer | Derivative | Restricted Stock Units | 83 | $0.00 | - | |
| Richard A. Richieri - Officer | Derivative | Restricted Stock Units | 131 | $0.00 | - | |
| Richard A. Richieri - Officer | Derivative | Restricted Stock Units | 208 | $0.00 | - | |
| Matthew R. Kwietniak - Officer | Option exercise | Common Stock, $0.001 par value | 2,763 | - | - | |
| Matthew R. Kwietniak - Officer | Open-market sale | Common Stock, $0.001 par value | 982 | $10.05 | $10K | |
| Matthew R. Kwietniak - Officer | Derivative | Restricted Stock Units | 630 | $0.00 | - | |
| Matthew R. Kwietniak - Officer | Derivative | Restricted Stock Units | 636 | $0.00 | - | |
| Matthew R. Kwietniak - Officer | Derivative | Restricted Stock Units | 1,497 | $0.00 | - | |
| Nicholas Stewart Green - Officer | Option exercise | Common Stock, $0.001 par value | 31,512 | - | - | |
| Nicholas Stewart Green - Officer | Open-market sale | Common Stock, $0.001 par value | 17,173 | $10.05 | $173K | |
| Nicholas Stewart Green - Officer | Derivative | Restricted Stock Units | 5,573 | $0.00 | - | |
| Nicholas Stewart Green - Officer | Derivative | Restricted Stock Units | 8,826 | $0.00 | - | |
| Nicholas Stewart Green - Officer | Derivative | Restricted Stock Units | 17,113 | $0.00 | - |
CDMO insider trading FAQ
What is the latest insider trade for CDMO?
Avid Bioservices, Inc. (CDMO) has filed no insider reports in the last 90 days. The most recent on record is dated 2024-12-27. The full record for CDMO runs to 15 Form 4 filings, the earliest from 2024-10-11. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CDMO stock?
No insider purchases of CDMO were filed in the last 90 days.
How many insiders are selling CDMO stock?
No insider sales of CDMO were filed in the last 90 days. 15 sales are on record for this company.
Where can I see CDMO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CDMO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Richard A. Richieri view on EDGAR
- - Matthew R. Kwietniak view on EDGAR
- - Nicholas Stewart Green view on EDGAR
- - Daniel R. Hart view on EDGAR
- - Nicholas Stewart Green view on EDGAR
- - Esther M. Alegria view on EDGAR
- - Jeanne Thoma view on EDGAR
- - Richard B. Hancock view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where CDMO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CDMO with a 7-day demo
- CDMO on your watchlist
- Every CDMO Form 4 filing on record
- Up to 3 months of CDMO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
